6-K filed Aug 12, 2026 at 16:01 ET
Brainsway Ltd. furnished an August 2026 investor deck via Form 6-K, presenting strong H1 2026 financial results: revenue grew +35% year-over-year, net income +34%, adjusted EBITDA +141%, and system shipments rose +42% to 125 units. The filing reiterates the company's strategic positioning as a Deep TMS platform leader with 4 FDA indications, expanding reimbursement, and a capital-light clinic network model. The deck is forward-looking and promotional in nature, reinforcing the growth narrative established in the prior 20-F annual report.